An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2010
At a glance
- Drugs Docetaxel; Topotecan
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 03 Sep 2005 New trial record.